Agile and flexible to accelerate value creation. Jubilant Therapeutics is open for partnering or strategic. collaborations with biotech, pharma, academia, research labs for: Accelerating clinical development and market launch of our ongoing programs. Discovery/development of new programs in synergistic areas. Conducting research with our drug candidates either as monotherapy or in combination to improve existing therapies in cancer and auto-immune disorders. In-licensing discovery assets. Research and pre-clinical studies.